120 related articles for article (PubMed ID: 11071855)
21. Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.
Okamoto H; Asamitsu K; Nishimura H; Kamatani N; Okamoto T
Biochem Biophys Res Commun; 2000 Dec; 279(2):494-9. PubMed ID: 11118314
[TBL] [Abstract][Full Text] [Related]
22. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
Broxmeyer HE; Cooper S; Hangoc G; Chang CH
Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
[TBL] [Abstract][Full Text] [Related]
23. Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling.
Kim H; Suh JM; Hwang ES; Kim DW; Chung HK; Song JH; Hwang JH; Park KC; Ro HK; Jo EK; Chang JS; Lee TH; Lee MS; Kohn LD; Shong M
J Immunol; 2003 Jul; 171(2):616-27. PubMed ID: 12847226
[TBL] [Abstract][Full Text] [Related]
24. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
25. Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters.
Kohoutek J; Blazek D; Peterlin BM
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17349-54. PubMed ID: 17088550
[TBL] [Abstract][Full Text] [Related]
26. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.
LeibundGut-Landmann S; Waldburger JM; Krawczyk M; Otten LA; Suter T; Fontana A; Acha-Orbea H; Reith W
Eur J Immunol; 2004 Jun; 34(6):1513-25. PubMed ID: 15162420
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA.
Lefebvre S; Moreau P; Dausset J; Carosella ED; Paul P
Placenta; 1999 May; 20(4):293-301. PubMed ID: 10329350
[TBL] [Abstract][Full Text] [Related]
28. Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs.
Märten A; Ziske C; Schöttker B; Weineck S; Renoth S; Buttgereit P; Schakowski F; König S; von Rücker A; Allera A; Schroers R; Sauerbruch T; Wittig B; Schmidt-Wolf IG
Cancer Gene Ther; 2001 Mar; 8(3):211-9. PubMed ID: 11332992
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of alloresponse by a human trophoblast non-coding RNA suppressing class II transactivator promoter III and major histocompatibility class II expression in murine B-lymphocytes.
Geirsson A; Bothwell AL; Hammond GL
J Heart Lung Transplant; 2004 Sep; 23(9):1077-81. PubMed ID: 15454174
[TBL] [Abstract][Full Text] [Related]
30. BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells.
Piskurich JF; Lin KI; Lin Y; Wang Y; Ting JP; Calame K
Nat Immunol; 2000 Dec; 1(6):526-32. PubMed ID: 11101876
[TBL] [Abstract][Full Text] [Related]
31. Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene.
Peijnenburg A; Van den Berg R; Van Eggermond MJ; Sanal O; Vossen JM; Lennon AM; Alcaïde-Loridan C; Van den Elsen PJ
Immunogenetics; 2000 Jan; 51(1):42-9. PubMed ID: 10663561
[TBL] [Abstract][Full Text] [Related]
32. Selective modulation of MHC class II chaperons by a novel IFN-γ-inducible class II transactivator variant in lung adenocarcinoma A549 cells.
Chiu BL; Li CH; Chang CC
Biochem Biophys Res Commun; 2013 Oct; 440(1):190-5. PubMed ID: 24055710
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the in vivo role of class II transactivator in basal and IFN-gamma induced class II expression in mouse tissue.
Ramassar V; Goes N; Hobart M; Halloran PF
Transplantation; 1996 Dec; 62(12):1901-7. PubMed ID: 8990384
[TBL] [Abstract][Full Text] [Related]
34. Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes.
Kanazawa S; Peterlin BM
Int Immunol; 2001 Jul; 13(7):951-8. PubMed ID: 11431425
[TBL] [Abstract][Full Text] [Related]
35. Induction of MHC class I expression by the MHC class II transactivator CIITA.
Martin BK; Chin KC; Olsen JC; Skinner CA; Dey A; Ozato K; Ting JP
Immunity; 1997 May; 6(5):591-600. PubMed ID: 9175837
[TBL] [Abstract][Full Text] [Related]
36. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.
Chang CH; Fontes JD; Peterlin M; Flavell RA
J Exp Med; 1994 Oct; 180(4):1367-74. PubMed ID: 7931070
[TBL] [Abstract][Full Text] [Related]
37. Class II transactivator regulates the expression of multiple genes involved in antigen presentation.
Chang CH; Flavell RA
J Exp Med; 1995 Feb; 181(2):765-7. PubMed ID: 7836928
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity.
Nickerson K; Sisk TJ; Inohara N; Yee CS; Kennell J; Cho MC; Yannie PJ; Nunez G; Chang CH
J Biol Chem; 2001 Jun; 276(22):19089-93. PubMed ID: 11279191
[TBL] [Abstract][Full Text] [Related]
39. In Primitive Zebrafish, MHC Class II Expression Is Regulated by IFN-γ, IRF1, and Two Forms of CIITA.
Hou J; Chen SN; Gan Z; Li N; Huang L; Huo HJ; Yang YC; Lu Y; Yin Z; Nie P
J Immunol; 2020 May; 204(9):2401-2415. PubMed ID: 32188757
[TBL] [Abstract][Full Text] [Related]
40. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA).
Riley JL; Westerheide SD; Price JA; Brown JA; Boss JM
Immunity; 1995 May; 2(5):533-43. PubMed ID: 7749984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
